Dr. Reinhard Koenig
President, CEO and Director
Dr. Reinhard Koenig is President and Chief Executive Officer of Glycotex and a member of the Board of Directors. Dr. Koenig has more than 18 years of experience in product development in the U.S. and Europe and has developed several successful products from Phase II through commercialization. He has held positions with Boehringer Mannheim, Genentech, Collagen Corporation and Questcor Pharmaceuticals, among others, and has driven product development for medical devices, biotechnology products and pharmaceuticals. Dr. Koenig received his medical degree at Philips University in Marburg, Germany. He also received his doctorate of medicine (specifically toxicology) from Philips University, Marburg.

Philip A. Johnston
Director
Mr. Johnston has been a director since September 2005. Mr. Johnston has more than 25 years of experience in the pharmaceutical industry. He has been a non-executive director of Novogen since January 1997 and Chairman of Novogen since January 2001. Mr. Johnston is also a director of Marshall Edwards, Inc. Mr. Johnston spent nine years as an executive director of Wellcome Australia Limited from June 1988 to September 1997. His responsibilities have encompassed production, distribution, quality assurance and consumer product development and he has been directly involved in the establishment of strategic alliances and joint ventures. Mr. Johnston has completed a number of executive development programs including programs at the University of New South Wales and the London Business School. Mr. Johnston has been a director of Lipa Pharmaceuticals Limited from July 2004 until November 2007.

William Dodge Rueckert
Director
Mr. Rueckert has been a director since October 2005. Mr. Rueckert is the Managing Member of Oyster Management Group LLC an investment fund specializing in community banks. Mr. Rueckert is a Director of Emergency Filtration Products, Inc., a public manufacturer and marketer of respiratory filtration devices and he is a member of the Board of Directors of Marshall Edwards, Inc., a subsidiary of Novogen Limited. Prior to his current positions, from 1991 to 2006 he was President and director of Rosow & Company, a private investment firm based in Connecticut. Mr. Rueckert was President and director of Eastern Capital Development, LLC from 1999 to 2005; Treasurer of Moore & Munger, Inc., a company with interests in the petroleum and resort development industries, from 1988 until 1990; and was President of United States Oil Company, a publicly traded oil exploration business, from 1981 to 1988. Among his many civic associations, Mr. Rueckert is director and president of the Cleveland H. Dodge Foundation, a private philanthropic organization in New York City and Chairman of the Board of the Trustees of Teachers College, Columbia University.

Katherine O. Szem
Director
Ms. Szem has been a director since November 2005. Ms. Szem has been Chief Financial Officer of Matrix Surgical Consulting Corp. since May 2001, Intellimed LLC since January 2003 and Intellimed Surgical Solutions LLC since February 2003. Matrix Surgical and the Intellimed companies are Szem family closely-held entities that are focused on developing, patenting and licensing surgical medical devices. Ms. Szem was the Managing Director of the Newport Beach, California office of Wealth and Tax Advisory Services, Inc., a wholly-owned subsidiary of HSBC Bank USA from July 2002 to December 2003. From January 1999 to June 2002, Ms. Szem was Managing Tax Partner of the Irvine, California office of Arthur Andersen. Ms. Szem received a Masters degree in Taxation from Seton Hall University and a Bachelor’s degree in Business Administration from San Francisco State University. Ms. Szem is a Certified Public Accountant in California, New Jersey and Hawaii, a member of the American Institute of Certified Public Accountants and a Certified Financial Planner.